Zymeworks Inc. (ZYME) shares soared 5.4% in the last trading session to close at $11.70. The move was backed by solid volume with far more shares changing hands than in a normal session.
LifeSci Capital analyst Charles Zhu initiated coverage with a Buy rating on Zymeworks (ZYME – Research Report) today and set a price target of $30.00. The company’s shares closed yesterday at ...
ZYMEWORKS ($ZYME) posted quarterly earnings results on Wednesday, March 5th. The company reported earnings of -$0.31 per share, missing estimates of -$0.10 by $0.21 ...